The discovery of tumor necrosis factor (TNF-α) as a crucial cytokine in the pathogenesis of ARDs as rheumatoid arthritis (RA) led to the development of the first group of biologic drugs: TNF-α inhibitor (5). This evidence concerns the gene TNF and acute respiratory distress syndrome.